Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Devoogdt

Showing results (91-100 of 153) with videos related to

Pageof 16
Sort By:
Molecular Imaging and Biology|June 25, 2016
Molecular Imaging with Kupffer Cell-Targeting Nanobodies for Diagnosis and Prognosis in Mouse Models of Liver PathogenesisFang Zheng, Amanda Sparkes, Patrick De Baetselier, et al.
Theranostics|August 22, 2017
Al<sup>18</sup>F-Labeling Of Heat-Sensitive Biomolecules for Positron Emission Tomography ImagingFrederik Cleeren, Joan Lecina, Muneer Ahamed, et al.
Frontiers in Immunology|October 6, 2023
Development and evaluation of nanobody tracers for noninvasive nuclear imaging of the immune-checkpoint TIGITKatty Zeven, Timo W M De Groof, Hannelore Ceuppens, et al.
Scientific Reports|November 4, 2023
In vitro modelling of local gene therapy with IL-15/IL-15Rα and a PD-L1 antagonist in melanoma reveals an interplay between NK cells and CD4<sup>+</sup> T cellsRobin Maximilian Awad, Yannick De Vlaeminck, Fien Meeus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2017
<sup>131</sup>I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer TreatmentMatthias D'Huyvetter, Jens De Vos, Catarina Xavier, et al.
Pharmaceuticals (Basel, Switzerland)|January 21, 2022
Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and TherapyCristina Barca, Christoph M Griessinger, Andreas Faust, et al.
Progress in Biophysics and Molecular Biology|March 30, 2020
Non-canonical roles of connexinsRaf Van Campenhout, Axelle Cooreman, Kaat Leroy, et al.
EJNMMI Radiopharmacy and Chemistry|July 24, 2024
Generic semi-automated radiofluorination strategy for single domain antibodies: [<sup>18</sup>F]FB-labelled single domain antibodies for PET imaging of fibroblast activation protein-α or folate receptor-α overexpression in cancerHerlinde Dierick, Laurent Navarro, Hannelore Ceuppens, et al.
Cell and Tissue Research|July 22, 2025
Nanobody-based Pannexin1 channel inhibitors increase survival after cardiac ischemia/reperfusionOlga M Rusiecka, Filippo Molica, Linda Clochard, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 2023
Preclinical Evaluation of a Radiotheranostic Single-Domain Antibody Against Fibroblast Activation Protein αYana Dekempeneer, Sam Massa, Francis Santens, et al.
Pageof 16

Showing results (91-100 of 153) with videos related to

Sort By:
Pageof 16
Molecular Imaging and Biology|June 25, 2016
Molecular Imaging with Kupffer Cell-Targeting Nanobodies for Diagnosis and Prognosis in Mouse Models of Liver PathogenesisFang Zheng, Amanda Sparkes, Patrick De Baetselier, et al.
Theranostics|August 22, 2017
Al<sup>18</sup>F-Labeling Of Heat-Sensitive Biomolecules for Positron Emission Tomography ImagingFrederik Cleeren, Joan Lecina, Muneer Ahamed, et al.
Frontiers in Immunology|October 6, 2023
Development and evaluation of nanobody tracers for noninvasive nuclear imaging of the immune-checkpoint TIGITKatty Zeven, Timo W M De Groof, Hannelore Ceuppens, et al.
Scientific Reports|November 4, 2023
In vitro modelling of local gene therapy with IL-15/IL-15Rα and a PD-L1 antagonist in melanoma reveals an interplay between NK cells and CD4<sup>+</sup> T cellsRobin Maximilian Awad, Yannick De Vlaeminck, Fien Meeus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2017
<sup>131</sup>I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer TreatmentMatthias D'Huyvetter, Jens De Vos, Catarina Xavier, et al.
Pharmaceuticals (Basel, Switzerland)|January 21, 2022
Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and TherapyCristina Barca, Christoph M Griessinger, Andreas Faust, et al.
Progress in Biophysics and Molecular Biology|March 30, 2020
Non-canonical roles of connexinsRaf Van Campenhout, Axelle Cooreman, Kaat Leroy, et al.
EJNMMI Radiopharmacy and Chemistry|July 24, 2024
Generic semi-automated radiofluorination strategy for single domain antibodies: [<sup>18</sup>F]FB-labelled single domain antibodies for PET imaging of fibroblast activation protein-α or folate receptor-α overexpression in cancerHerlinde Dierick, Laurent Navarro, Hannelore Ceuppens, et al.
Cell and Tissue Research|July 22, 2025
Nanobody-based Pannexin1 channel inhibitors increase survival after cardiac ischemia/reperfusionOlga M Rusiecka, Filippo Molica, Linda Clochard, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 2023
Preclinical Evaluation of a Radiotheranostic Single-Domain Antibody Against Fibroblast Activation Protein αYana Dekempeneer, Sam Massa, Francis Santens, et al.
Pageof 16